{"id":108315,"date":"2021-05-25T08:09:18","date_gmt":"2021-05-25T08:09:18","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108315"},"modified":"2021-05-25T08:09:18","modified_gmt":"2021-05-25T08:09:18","slug":"hereditary-spherocytic-hemolytic-anemia","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/","title":{"rendered":"Hereditary spherocytic hemolytic anemia"},"content":{"rendered":"<p>The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-108315","post","type-post","status-publish","format-standard","hentry","category-h"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hereditary spherocytic hemolytic anemia - Definition of Hereditary spherocytic hemolytic anemia<\/title>\n<meta name=\"description\" content=\"The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hereditary spherocytic hemolytic anemia - Definition of Hereditary spherocytic hemolytic anemia\" \/>\n<meta property=\"og:description\" content=\"The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-25T08:09:18+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/\",\"name\":\"Hereditary spherocytic hemolytic anemia - Definition of Hereditary spherocytic hemolytic anemia\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-25T08:09:18+00:00\",\"dateModified\":\"2021-05-25T08:09:18+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hereditary spherocytic hemolytic anemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hereditary spherocytic hemolytic anemia - Definition of Hereditary spherocytic hemolytic anemia","description":"The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/","og_locale":"en_US","og_type":"article","og_title":"Hereditary spherocytic hemolytic anemia - Definition of Hereditary spherocytic hemolytic anemia","og_description":"The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/","og_site_name":"Glossary","article_published_time":"2021-05-25T08:09:18+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/","name":"Hereditary spherocytic hemolytic anemia - Definition of Hereditary spherocytic hemolytic anemia","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-25T08:09:18+00:00","dateModified":"2021-05-25T08:09:18+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The blood cells in individuals with hereditary spherocytic hemolytic anemia (HSHA) are sphere-shaped due to a defect within the blood cell as a result of a metabolic defect. Because of the cells\u2019 shape, they are not readily passed through the small blood vessels of the spleen and are often prematurely destroyed by the spleen. The incidence rate of HSHA in the United States is estimated to be approximately 1 in 5,000 individuals and usually affects Caucasian individuals of northern European ancestry; it is rarely found in other racial groups. The disorder is autosomal dominant, with 50% of the siblings affected. However, in a small number of cases, neither parent has the defect and the expression of the disorder may be due to a recessive form of the disorder or to spontaneous mutation. The severity of the disorder depends upon whether the individual can compensate for the loss of red blood cells by producing more cells. If the bone marrow temporarily halts production of new blood cells due to infection, the individual may experience an aplastic crisis as a result of the loss of blood.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/hereditary-spherocytic-hemolytic-anemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Hereditary spherocytic hemolytic anemia"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108315"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108315\/revisions"}],"predecessor-version":[{"id":108316,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108315\/revisions\/108316"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}